相关实验视频
Updated: Jun 6, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.1K
在美国的妇科瘤学临床试验可用性的地理差异
Mary Regina Boland1,2,3, Elizabeth Tubridy4, Sebastian Spataro Solorzano5,6,7
1Department of Data Science in Mathematics, Herbert W. Boyer School of Natural Sciences, Mathematics, and Computing, Saint Vincent College, Latrobe, Pennsylvania.
JAMA network open
|November 26, 2024
概括
在妇科癌症临床试验获取方面存在地理差异,面临更高社会脆弱性的州试验较少. 解决这些不平等问题对于平等获得参与癌症研究至关重要.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 少数群体在妇科癌症临床试验参与方面面临着有记录的差异.
- 在这些相同的人群中观察到高水平的子宫内膜癌.
- 临床试验的地理接近是公平获取的关键因素.
研究的目的:
- 分析美国全美妇科癌症临床试验的地理分布.
- 为了确定临床试验可用性的州级差异.
- 调查试验分布和状态特征之间的关联.
主要方法:
- 在clinicaltrials.gov (2013-2024) 上发布的妇科癌症试验的横截面分析.
- 国家一级评估人均试验数量.
- 使用州人口统计和社会脆弱性数据 (FEMA预期的年度损失) 的相关性分析.
主要成果:
- 分析了1561项侵袭性妇科癌症试验 (卵巢,宫,子宫内膜等). ) 的情况.
- 少数民族人口占主导地位的州的人均试验较少,尽管在全国范围内没有统计学意义.
- 社会脆弱性较高的州 (FEMA预计的年损失) 人均试验明显减少.
结论:
- 妇科癌症临床试验的可用性在美国分布不均.
- 具有高度社会脆弱性和显著少数民族人口的国家对这些试验的访问率较低.
- 需要有针对性的努力,以改善所有人群平等获得癌症临床试验的机会.
更多相关视频
相关概念视频
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91
Disorders of the Female Reproductive System
328
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
328

